Shota Shimizu

Yonago, 6838504, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Timing of Immune Checkpoint Inhibitor Initiation and Overall Survival in Advanced Gastric Cancer: A Multicenter Real-World Study Using Clone-Censor-Weight Analysis.

Timing of Immune Checkpoint Inhibitor Initiation and Overall Survival in Advanced Gastric Cancer: A Multicenter Real-World Study Using Clone-Censor-Weight Analysis.

Journal: Journal of gastrointestinal cancer

Published: May 15, 2026

Unfavorable Outcomes of T3N0 Remnant Gastric Cancer After Distal Gastrectomy.

Unfavorable Outcomes of T3N0 Remnant Gastric Cancer After Distal Gastrectomy.

Journal: Anticancer research

Published: March 23, 2026

Preoperative Cachexia Index Predicts Overall Survival Following Curative Resection for Remnant Gastric Cancer.

Preoperative Cachexia Index Predicts Overall Survival Following Curative Resection for Remnant Gastric Cancer.

Journal: Anticancer research

Published: February 27, 2026

Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.

Prognostic significance of the C-reactive protein-albumin-lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy.

Journal: Surgery today

Published: January 04, 2026

Roles of GPX4 and FSP1 in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy.

Roles of GPX4 and FSP1 in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy.

Journal: Anticancer research

Published: December 12, 2025

Interaction between gastric cancer organoids and peritoneal mesothelial cells suppresses the growth of gastric cancer organoids and induces drug resistance.

Interaction between gastric cancer organoids and peritoneal mesothelial cells suppresses the growth of gastric cancer organoids and induces drug resistance.

Journal: Human cell

Published: July 28, 2025

An Approach to Minimally Invasive Treatment in Patients With Gastric Cancer Aged Over 80 Years.

An Approach to Minimally Invasive Treatment in Patients With Gastric Cancer Aged Over 80 Years.

Journal: Anticancer research

Published: May 15, 2025

History and current developments of RERF dosimetry.

History and current developments of RERF dosimetry.

Journal: Carcinogenesis

Published: April 11, 2025

Comparison of Postoperative Outcomes of Laparoscopic Versus Open Gastrectomy in Older Patients With Gastric Cancer.

Comparison of Postoperative Outcomes of Laparoscopic Versus Open Gastrectomy in Older Patients With Gastric Cancer.

Journal: Anticancer research

Published: February 10, 2025

A higher preoperative cachexia index can result in the sufficient administration of S-1 adjuvant chemotherapy and lead to a good prognosis for elderly patients with stage II/III gastric cancer.

A higher preoperative cachexia index can result in the sufficient administration of S-1 adjuvant chemotherapy and lead to a good prognosis for elderly patients with stage II/III gastric cancer.

Journal: Surgery today

Published: December 16, 2024

Impact of Lymphocyte/Monocyte Ratio on Outcomes in Patients with Remnant Gastric Cancer After Gastrectomy.

Impact of Lymphocyte/Monocyte Ratio on Outcomes in Patients with Remnant Gastric Cancer After Gastrectomy.

Journal: Yonago acta medica

Published: September 19, 2024

Change and predictors of body composition after gastrectomy for gastric cancer during first postoperative year.

Change and predictors of body composition after gastrectomy for gastric cancer during first postoperative year.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Published: September 06, 2024

Showing 1-12 of 51

Last Updated: 09/26/2026